StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report issued on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Price Performance
BLPH opened at $0.06 on Tuesday. Bellerophon Therapeutics has a 12-month low of $0.03 and a 12-month high of $11.15. The stock has a market capitalization of $673,873.00, a PE ratio of -0.07 and a beta of 0.67. The firm’s fifty day moving average price is $0.05 and its 200 day moving average price is $0.05.
About Bellerophon Therapeutics
See Also
- Five stocks we like better than Bellerophon Therapeutics
- What is the NASDAQ Stock Exchange?
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Where Do I Find 52-Week Highs and Lows?
- Hilton Demonstrates Asset Light is Right for Investors
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
